In an unpublished work, plinabulin reduced neutropenia induced by docetaxel in non-tumor-bearing C57BL/6 mice [Ghosh et al., AACR 2018, Abstract 4805], with a mechanism thought to involve increased production of neutrophils in the bone marrow, possibly by relieving a docetaxel-induced accumulation of murine HSPC (Lin−Sca1+c-Kit+ or LSK cells) observed 5 days after treatment. Here, KIT is linked to neutropenia.